FRIDAY, NOVEMBER 24, 2017

HHS chooses regional centers to be special pathogen treatment sites

The U.S. Department of Health and Human Services (HHS) said Friday it has chosen nine health departments and associated partner hospitals as special regional treatment centers in order to improve the nation’s response capabilities to infectious diseases, such as Ebola. Read More »

Total of Indiana residents testing positive for TB rises to 85

The Indiana State Department of Health said on Friday that the number of positive tuberculosis (TB) skin-tested individuals has increased from 54 to 85. As of Friday, all of these patients have been tied to a student recently diagnosed with TB. The student is now quarantined and receiving treatment. Read More »

Catalent gets grant, joins effort to improve vaccine properties

Catalent -- a global provider of advanced delivery technologies, as well as development solutions, for biologics, drugs and consumer health products -- recently said it has accepted a grant as part of a consortium to fund the research, development and production of thermo-stable and cold-chain independent nano-pharmaceutical virosome-based vaccine candidates. Read More »

Health Department: State's Lyme disease cases surge last year

The Pennsylvania Department of Health released a report last week on 2014's Lyme disease cases by county. The report showed a 25 percent increase in cases overall throughout the state, with 7,400 total cases last year, compared with 5,900 cases in 2013. Health experts attribute the surge to better reporting, improved awareness of Lyme disease and heightened monitoring efforts, especially in Allegheny County. Read More »

Novartis holds workshop to help eliminate malaria in Africa

Novartis said Friday it recently held the 14th annual National Malaria Control Program (NMCP) Best Practice Sharing Workshop in Mozambique in order to encourage African nations to eliminate malaria.Africa currently faces a major turning point in battling malaria. The three-day workshop was called in order for malaria experts from more than 35 African countries to exchange and discuss innovative strategies and tools to eliminate malaria. Read More »

Mississippi reports first chikungunya case for 2015

The Mississippi State Department of Health said Monday it confirmed the state's first case of chikungunya virus this year.The state's first case this year involves a Mississippi resident who recently returned from Honduras. Read More »

Hualan is first influenza vaccine manufacturer in China to get WHO approval

On June 10 -- a split virion, inactivated flu vaccine developed by China-based Hualan Biological Engineering Inc. -- has achieved pre-qualification through the World Health Organization (WHO). Read More »

Tennessee officials issue MERS health alert

Late last week, the Tennessee Department of Health (TDH) issued an alert to health care providers in response to a Korean outbreak of Middle East respiratory syndrome coronavirus (MERS Co-V). Read More »

World Health Organization committee discusses MERS

The World Health Organization's (WHO) Emergency Committee recently met with the director-general under the International Health Regulations 2005 to discuss the Middle East respiratory syndrome coronavirus (MERS-CoV) at the EC’s ninth meeting Tuesday. Read More »

University of Georgia finds personal experience crucial to influenza vaccination decision

A study from the University of Georgia (UGA) indicates that personal experience relating to receiving the annual influenza vaccine can play a part in whether or not someone chooses to be vaccinated, researchers said Monday. Read More »

Penn State study shows killer T cells critical to vaccines

Researchers from Penn State have discovered the human immune system needs enough killer T cells to respond to viral threats, which may be a critical component for more effective vaccines in the future. Read More »

Study of Ebola survivors opens in Liberia

A joint study between the U.S. and Liberia opened Wednesday to study post-infection health effects in those who have survived the Ebola virus. Read More »

C. Evan Ballantyne takes over as chief financial officer at Agenus

Agenus, Inc., an immunology company that creates novel treatments for cancers and similar diseases, said Wednesday that C. Evan Ballantyne will be its new chief financial officer.Ballantyne has over 30 years of experience with financial and operational work. Read More »

SIRION Biotech plans new office in Boston region

SIRION Biotech, a top viral vector platform company that is renowned for developing high quality viral vector solutions for academic and industry partners, recently announce that it intends to established a new office within the area of Boston, Massachusetts. SIRION has partnered with the Massachusetts Life Sciences Center (MLSC) to find an office and lab space. Read More »

New mechanism that attacks viral infections discovered

Researchers at medical centers in universities in Mainz and Freiburg, Germany, have discovered a mechanism used by the innate immune system to control viral infections such as rotavirus -- the most common cause of pediatric diarrhea. Read More »

CDC issues advisory on avian flu

The U.S. Centers for Disease Control and Prevention (CDC) recently issued a Health Alert Network (HAN) advisory regarding the highly pathogenic avian influenza A H5 virus.The CDC issued the advisory June 2 to remind public health workers and providers that the potential of human infection exists and to make known the CDC's recommendations for patient evaluation and testing and infection control. Read More »

BiondVax to present immunoassay workshop at EDUFULVAC event

Israel-based BiondVax Pharmaceuticals, Ltd. said Monday it will present a workshop Thursday and Friday in London at the invitation of EDUFULVAC, (EDUcate inFLUenza VACcine).  EDUFULVAC is a European consortium assembled by the European Vaccine Initiative in Germany and the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH) in the United States. Read More »

Targeted protein may modify malaria vaccines

Experts recently discovered that a new kind of vaccine that blocks parasite transmission may be crucial to eliminating malaria. Read More »

Lessons from MERS outbreak in South Korea

A recent editorial in the International Journal of Infectious Diseases outlines some lessons to be learned from the most recent Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea. Read More »

USAID awards Leidos $23.7 mln contract to fight malaria

The US Agency for International Development contracted health and security solutions company Leidos to help develop a vaccine for malaria. Read More »